Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127051) titled 'Mixed-reality Immersive Neuro-cognitive-ophthalmic Diagnostic (MIND) platform' on June 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Department of Ophthalmology and Visual Sciences (DOVS), The Chinese University of Hong Kong
Condition:
Neurocognitive or neuro-ophthalmological conditions
Intervention:
Group A (Disease Group): 200 subjects with known or newly screened neurocognitive or neuro-ophthalmological conditions:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-30
Target Sample Size: Group A (Disease Group): 200 subjects with kn...